1 Market Overview
1.1 Drugs for Ophthalmology Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drugs for Ophthalmology Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Gels
1.2.3 Eye Solutions
1.2.4 Capsules & Tablets
1.2.5 Eye Drops
1.2.6 Ointments
1.3 Market Analysis by Application
1.3.1 Overview: Global Drugs for Ophthalmology Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Global Drugs for Ophthalmology Market Size & Forecast
1.4.1 Global Drugs for Ophthalmology Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drugs for Ophthalmology Sales in Volume (2017-2028)
1.4.3 Global Drugs for Ophthalmology Price (2017-2028)
1.5 Global Drugs for Ophthalmology Production Capacity Analysis
1.5.1 Global Drugs for Ophthalmology Total Production Capacity (2017-2028)
1.5.2 Global Drugs for Ophthalmology Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drugs for Ophthalmology Market Drivers
1.6.2 Drugs for Ophthalmology Market Restraints
1.6.3 Drugs for Ophthalmology Trends Analysis
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan Drugs for Ophthalmology Product and Services
2.1.4 Allergan Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Aerie Pharmaceuticals
2.2.1 Aerie Pharmaceuticals Details
2.2.2 Aerie Pharmaceuticals Major Business
2.2.3 Aerie Pharmaceuticals Drugs for Ophthalmology Product and Services
2.2.4 Aerie Pharmaceuticals Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Drugs for Ophthalmology Product and Services
2.3.4 Pfizer Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Valeant
2.4.1 Valeant Details
2.4.2 Valeant Major Business
2.4.3 Valeant Drugs for Ophthalmology Product and Services
2.4.4 Valeant Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Drugs for Ophthalmology Product and Services
2.5.4 Bayer Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Genentech
2.6.1 Genentech Details
2.6.2 Genentech Major Business
2.6.3 Genentech Drugs for Ophthalmology Product and Services
2.6.4 Genentech Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Drugs for Ophthalmology Product and Services
2.7.4 Novartis Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Regeneron
2.8.1 Regeneron Details
2.8.2 Regeneron Major Business
2.8.3 Regeneron Drugs for Ophthalmology Product and Services
2.8.4 Regeneron Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Takeda
2.9.1 Takeda Details
2.9.2 Takeda Major Business
2.9.3 Takeda Drugs for Ophthalmology Product and Services
2.9.4 Takeda Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Santen Pharmaceutical
2.10.1 Santen Pharmaceutical Details
2.10.2 Santen Pharmaceutical Major Business
2.10.3 Santen Pharmaceutical Drugs for Ophthalmology Product and Services
2.10.4 Santen Pharmaceutical Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drugs for Ophthalmology Breakdown Data by Manufacturer
3.1 Global Drugs for Ophthalmology Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drugs for Ophthalmology Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drugs for Ophthalmology
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Ophthalmology Manufacturer Market Share in 2021
3.4.2 Top 6 Drugs for Ophthalmology Manufacturer Market Share in 2021
3.5 Global Drugs for Ophthalmology Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drugs for Ophthalmology Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drugs for Ophthalmology Market Size by Region
4.1.1 Global Drugs for Ophthalmology Sales in Volume by Region (2017-2028)
4.1.2 Global Drugs for Ophthalmology Revenue by Region (2017-2028)
4.2 North America Drugs for Ophthalmology Revenue (2017-2028)
4.3 Europe Drugs for Ophthalmology Revenue (2017-2028)
4.4 Asia-Pacific Drugs for Ophthalmology Revenue (2017-2028)
4.5 South America Drugs for Ophthalmology Revenue (2017-2028)
4.6 Middle East and Africa Drugs for Ophthalmology Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Drugs for Ophthalmology Sales in Volume by Type (2017-2028)
5.2 Global Drugs for Ophthalmology Revenue by Type (2017-2028)
5.3 Global Drugs for Ophthalmology Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Drugs for Ophthalmology Sales in Volume by Application (2017-2028)
6.2 Global Drugs for Ophthalmology Revenue by Application (2017-2028)
6.3 Global Drugs for Ophthalmology Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Drugs for Ophthalmology Sales by Type (2017-2028)
7.2 North America Drugs for Ophthalmology Sales by Application (2017-2028)
7.3 North America Drugs for Ophthalmology Market Size by Country
7.3.1 North America Drugs for Ophthalmology Sales in Volume by Country (2017-2028)
7.3.2 North America Drugs for Ophthalmology Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Drugs for Ophthalmology Sales by Type (2017-2028)
8.2 Europe Drugs for Ophthalmology Sales by Application (2017-2028)
8.3 Europe Drugs for Ophthalmology Market Size by Country
8.3.1 Europe Drugs for Ophthalmology Sales in Volume by Country (2017-2028)
8.3.2 Europe Drugs for Ophthalmology Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drugs for Ophthalmology Sales by Type (2017-2028)
9.2 Asia-Pacific Drugs for Ophthalmology Sales by Application (2017-2028)
9.3 Asia-Pacific Drugs for Ophthalmology Market Size by Region
9.3.1 Asia-Pacific Drugs for Ophthalmology Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drugs for Ophthalmology Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Drugs for Ophthalmology Sales by Type (2017-2028)
10.2 South America Drugs for Ophthalmology Sales by Application (2017-2028)
10.3 South America Drugs for Ophthalmology Market Size by Country
10.3.1 South America Drugs for Ophthalmology Sales in Volume by Country (2017-2028)
10.3.2 South America Drugs for Ophthalmology Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drugs for Ophthalmology Sales by Type (2017-2028)
11.2 Middle East & Africa Drugs for Ophthalmology Sales by Application (2017-2028)
11.3 Middle East & Africa Drugs for Ophthalmology Market Size by Country
11.3.1 Middle East & Africa Drugs for Ophthalmology Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drugs for Ophthalmology Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Drugs for Ophthalmology and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drugs for Ophthalmology
12.3 Drugs for Ophthalmology Production Process
12.4 Drugs for Ophthalmology Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drugs for Ophthalmology Typical Distributors
13.3 Drugs for Ophthalmology Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Drugs for Ophthalmology Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drugs for Ophthalmology Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Allergan Basic Information, Manufacturing Base and Competitors
Table 4. Allergan Major Business
Table 5. Allergan Drugs for Ophthalmology Product and Services
Table 6. Allergan Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Aerie Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Aerie Pharmaceuticals Major Business
Table 9. Aerie Pharmaceuticals Drugs for Ophthalmology Product and Services
Table 10. Aerie Pharmaceuticals Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Drugs for Ophthalmology Product and Services
Table 14. Pfizer Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Valeant Basic Information, Manufacturing Base and Competitors
Table 16. Valeant Major Business
Table 17. Valeant Drugs for Ophthalmology Product and Services
Table 18. Valeant Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Major Business
Table 21. Bayer Drugs for Ophthalmology Product and Services
Table 22. Bayer Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Genentech Basic Information, Manufacturing Base and Competitors
Table 24. Genentech Major Business
Table 25. Genentech Drugs for Ophthalmology Product and Services
Table 26. Genentech Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Novartis Basic Information, Manufacturing Base and Competitors
Table 28. Novartis Major Business
Table 29. Novartis Drugs for Ophthalmology Product and Services
Table 30. Novartis Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Regeneron Basic Information, Manufacturing Base and Competitors
Table 32. Regeneron Major Business
Table 33. Regeneron Drugs for Ophthalmology Product and Services
Table 34. Regeneron Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Takeda Basic Information, Manufacturing Base and Competitors
Table 36. Takeda Major Business
Table 37. Takeda Drugs for Ophthalmology Product and Services
Table 38. Takeda Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Santen Pharmaceutical Major Business
Table 41. Santen Pharmaceutical Drugs for Ophthalmology Product and Services
Table 42. Santen Pharmaceutical Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Drugs for Ophthalmology Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Drugs for Ophthalmology Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Drugs for Ophthalmology, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Drugs for Ophthalmology Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Drugs for Ophthalmology Production Site of Key Manufacturer
Table 48. Drugs for Ophthalmology New Entrant and Capacity Expansion Plans
Table 49. Drugs for Ophthalmology Mergers & Acquisitions in the Past Five Years
Table 50. Global Drugs for Ophthalmology Sales by Region (2017-2022) & (K Units)
Table 51. Global Drugs for Ophthalmology Sales by Region (2023-2028) & (K Units)
Table 52. Global Drugs for Ophthalmology Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Drugs for Ophthalmology Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Drugs for Ophthalmology Sales by Type (2017-2022) & (K Units)
Table 55. Global Drugs for Ophthalmology Sales by Type (2023-2028) & (K Units)
Table 56. Global Drugs for Ophthalmology Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Drugs for Ophthalmology Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Drugs for Ophthalmology Price by Type (2017-2022) & (USD/Unit)
Table 59. Global Drugs for Ophthalmology Price by Type (2023-2028) & (USD/Unit)
Table 60. Global Drugs for Ophthalmology Sales by Application (2017-2022) & (K Units)
Table 61. Global Drugs for Ophthalmology Sales by Application (2023-2028) & (K Units)
Table 62. Global Drugs for Ophthalmology Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Drugs for Ophthalmology Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Drugs for Ophthalmology Price by Application (2017-2022) & (USD/Unit)
Table 65. Global Drugs for Ophthalmology Price by Application (2023-2028) & (USD/Unit)
Table 66. North America Drugs for Ophthalmology Sales by Country (2017-2022) & (K Units)
Table 67. North America Drugs for Ophthalmology Sales by Country (2023-2028) & (K Units)
Table 68. North America Drugs for Ophthalmology Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Drugs for Ophthalmology Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Drugs for Ophthalmology Sales by Type (2017-2022) & (K Units)
Table 71. North America Drugs for Ophthalmology Sales by Type (2023-2028) & (K Units)
Table 72. North America Drugs for Ophthalmology Sales by Application (2017-2022) & (K Units)
Table 73. North America Drugs for Ophthalmology Sales by Application (2023-2028) & (K Units)
Table 74. Europe Drugs for Ophthalmology Sales by Country (2017-2022) & (K Units)
Table 75. Europe Drugs for Ophthalmology Sales by Country (2023-2028) & (K Units)
Table 76. Europe Drugs for Ophthalmology Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Drugs for Ophthalmology Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Drugs for Ophthalmology Sales by Type (2017-2022) & (K Units)
Table 79. Europe Drugs for Ophthalmology Sales by Type (2023-2028) & (K Units)
Table 80. Europe Drugs for Ophthalmology Sales by Application (2017-2022) & (K Units)
Table 81. Europe Drugs for Ophthalmology Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Drugs for Ophthalmology Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Drugs for Ophthalmology Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Drugs for Ophthalmology Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Drugs for Ophthalmology Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Drugs for Ophthalmology Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Drugs for Ophthalmology Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Drugs for Ophthalmology Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Drugs for Ophthalmology Sales by Application (2023-2028) & (K Units)
Table 90. South America Drugs for Ophthalmology Sales by Country (2017-2022) & (K Units)
Table 91. South America Drugs for Ophthalmology Sales by Country (2023-2028) & (K Units)
Table 92. South America Drugs for Ophthalmology Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Drugs for Ophthalmology Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Drugs for Ophthalmology Sales by Type (2017-2022) & (K Units)
Table 95. South America Drugs for Ophthalmology Sales by Type (2023-2028) & (K Units)
Table 96. South America Drugs for Ophthalmology Sales by Application (2017-2022) & (K Units)
Table 97. South America Drugs for Ophthalmology Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Drugs for Ophthalmology Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Drugs for Ophthalmology Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Drugs for Ophthalmology Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Drugs for Ophthalmology Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Drugs for Ophthalmology Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Drugs for Ophthalmology Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Drugs for Ophthalmology Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Drugs for Ophthalmology Sales by Application (2023-2028) & (K Units)
Table 106. Drugs for Ophthalmology Raw Material
Table 107. Key Manufacturers of Drugs for Ophthalmology Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Drugs for Ophthalmology Typical Distributors
Table 111. Drugs for Ophthalmology Typical Customers
List of Figures
Figure 1. Drugs for Ophthalmology Picture
Figure 2. Global Drugs for Ophthalmology Revenue Market Share by Type in 2021
Figure 3. Gels
Figure 4. Eye Solutions
Figure 5. Capsules & Tablets
Figure 6. Eye Drops
Figure 7. Ointments
Figure 8. Global Drugs for Ophthalmology Revenue Market Share by Application in 2021
Figure 9. Hospital
Figure 10. Retail Pharmacy
Figure 11. Global Drugs for Ophthalmology Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Drugs for Ophthalmology Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Drugs for Ophthalmology Sales (2017-2028) & (K Units)
Figure 14. Global Drugs for Ophthalmology Price (2017-2028) & (USD/Unit)
Figure 15. Global Drugs for Ophthalmology Production Capacity (2017-2028) & (K Units)
Figure 16. Global Drugs for Ophthalmology Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Drugs for Ophthalmology Market Drivers
Figure 18. Drugs for Ophthalmology Market Restraints
Figure 19. Drugs for Ophthalmology Market Trends
Figure 20. Global Drugs for Ophthalmology Sales Market Share by Manufacturer in 2021
Figure 21. Global Drugs for Ophthalmology Revenue Market Share by Manufacturer in 2021
Figure 22. Drugs for Ophthalmology Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Drugs for Ophthalmology Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Drugs for Ophthalmology Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Drugs for Ophthalmology Sales Market Share by Region (2017-2028)
Figure 26. Global Drugs for Ophthalmology Revenue Market Share by Region (2017-2028)
Figure 27. North America Drugs for Ophthalmology Revenue (2017-2028) & (USD Million)
Figure 28. Europe Drugs for Ophthalmology Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Drugs for Ophthalmology Revenue (2017-2028) & (USD Million)
Figure 30. South America Drugs for Ophthalmology Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Drugs for Ophthalmology Revenue (2017-2028) & (USD Million)
Figure 32. Global Drugs for Ophthalmology Sales Market Share by Type (2017-2028)
Figure 33. Global Drugs for Ophthalmology Revenue Market Share by Type (2017-2028)
Figure 34. Global Drugs for Ophthalmology Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Drugs for Ophthalmology Sales Market Share by Application (2017-2028)
Figure 36. Global Drugs for Ophthalmology Revenue Market Share by Application (2017-2028)
Figure 37. Global Drugs for Ophthalmology Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Drugs for Ophthalmology Sales Market Share by Type (2017-2028)
Figure 39. North America Drugs for Ophthalmology Sales Market Share by Application (2017-2028)
Figure 40. North America Drugs for Ophthalmology Sales Market Share by Country (2017-2028)
Figure 41. North America Drugs for Ophthalmology Revenue Market Share by Country (2017-2028)
Figure 42. United States Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Drugs for Ophthalmology Sales Market Share by Type (2017-2028)
Figure 46. Europe Drugs for Ophthalmology Sales Market Share by Application (2017-2028)
Figure 47. Europe Drugs for Ophthalmology Sales Market Share by Country (2017-2028)
Figure 48. Europe Drugs for Ophthalmology Revenue Market Share by Country (2017-2028)
Figure 49. Germany Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Drugs for Ophthalmology Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Drugs for Ophthalmology Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Drugs for Ophthalmology Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Drugs for Ophthalmology Revenue Market Share by Region (2017-2028)
Figure 58. China Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Drugs for Ophthalmology Sales Market Share by Type (2017-2028)
Figure 65. South America Drugs for Ophthalmology Sales Market Share by Application (2017-2028)
Figure 66. South America Drugs for Ophthalmology Sales Market Share by Country (2017-2028)
Figure 67. South America Drugs for Ophthalmology Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Drugs for Ophthalmology Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Drugs for Ophthalmology Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Drugs for Ophthalmology Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Drugs for Ophthalmology Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Drugs for Ophthalmology in 2021
Figure 79. Manufacturing Process Analysis of Drugs for Ophthalmology
Figure 80. Drugs for Ophthalmology Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source

※参考情報 眼科用医薬品は、目および視覚器官に関連する疾患や障害の診断、治療、予防を目的とした医薬品のことを指します。眼科は非常に専門的な分野であり、眼の構造や機能、疾患の背景理解が要求されます。眼科用医薬品にはさまざまな種類があり、それぞれに具体的な作用機序や適応があります。 眼科用医薬品は主に、眼科疾患の治療を目的としたものと、眼の検査や手術の補助をするものに分けられます。治療薬としては、抗菌薬、抗ウイルス薬、抗アレルギー薬、抗炎症薬、緑内障治療薬、白内障手術後の療法薬などがあります。また、眼の検査や手術の際に使用される薬剤には、散瞳薬、局所麻酔薬、染色薬などが含まれます。 眼科疾患にはさまざまな種類があり、それに応じて使用される医薬品も多岐にわたります。例えば、結膜炎や角膜炎などの感染症には抗菌薬が使われます。これらの抗菌薬は通常、点眼液や軟膏の形式で投与されます。ウイルス性疾患に対しては、抗ウイルス薬が用いられ、特にヘルペスウイルスによる眼感染に対しては、アシクロビルなどの薬剤が効果を示します。 アレルギー性結膜炎などアレルギーに関連する疾患には、抗ヒスタミン薬やステロイド薬が使われます。これらは炎症を抑え、かゆみや赤みの軽減を目的とします。眼科領域では、局所投与が基本であり、全身副作用を軽減できるというメリットがあります。 慢性疾患である緑内障に対する治療薬も重要です。緑内障治療薬は眼圧を低下させることを目的としており、β遮断薬、α2アドレナリン作動薬、プロスタグランド誘導体、炭酸脱水酵素阻害薬などが挙げられます。これらの薬剤も点眼液の形で使用され、患者の外来での経過観察が行われます。 白内障に関しては、手術が主な治療法とされていますが、手術後に必要な薬剤も存在します。ステロイド点眼薬や抗生物質点眼薬が術後感染や炎症の予防を目的として投与されます。 眼科用医薬品は、その形態も非常に多様です。点眼液や軟膏は最も一般的な形態ですが、内服薬や注射剤として使用されることもあります。また、最近ではドラッグデリバリーシステム（DDS）技術の進歩があり、眼内に直接投与することで効果的な治療が可能になるなど新しい療法も開発されています。ビオスのような剤形では、微細な粒子を眼内に持続的に放出することで、効果を持続させることができます。 さらに、眼科用医薬品は早期診断や治療に役立つ診断薬や検査薬もあります。散瞳薬は眼底検査を行う際に瞳孔を拡張させる目的で使用され、局所麻酔薬は手術前の痛みを和らげるのに役立ちます。染色薬は角膜の障害を確認するために用いられ、フルオレセインなどが代表的です。 最近では、遺伝子治療や細胞治療などの新しい治療法も開発されており、眼疾患に対するアプローチが革新されています。これにより、従来の治療法では難しかった疾患に対しても新しい治療の可能性が提供されています。 また、テクノロジーの進化により、デジタルヘルスやAI（人工知能）を活用した眼科領域での医療も注目されています。遠隔医療を通じて患者の視覚的健康を監視したり、AIを用いて画像診断を支援することができるようになっています。これらの技術は、患者の利便性を向上させ、より早期の診断・治療を可能にする手段として期待されています。 このように眼科用医薬品は多くの側面を持ち、技術の進歩とともに進化し続けています。目は私たちの生活において非常に重要な器官であり、その健康を維持するためには、適切な医療と薬品の利用が欠かせません。医療の現場での眼科用医薬品の活用は、視覚障害の予防や治療に貢献し、患者の生活の質を向上させる重要な役割を果たしています。眼科用医薬品の研究と開発は、今後も進展し続けるでしょう。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer